ConductScience.org, home

Paper33552157

Hypoxia Molecular Characterization in Hepatocellular Carcinoma Identifies One Risk Signature and Two Nomograms for Clinical Management.

Liu Z and 6 others. J Oncol, 2021. Cited by 27 papers, by iCite.

Cite this record

ConductScience Library. Hypoxia Molecular Characterization in Hepatocellular Carcinoma Identifies One Risk Signature and Two Nomograms for Clinical Management. Papers, record 33552157. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33552157

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hypoxia Molecular Characterization in Hepatocellular Carcinoma Identifies One Risk Signature and Two Nomograms for Clinical Management.
PubMed
Journal
J Oncol
PubMed
Year
2021
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
1.24
iCite
Revised in PubMed
2024-08-06
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu ZZaoquhttps://orcid.org/0000-0002-0452-742X
2Liu LLong
3Lu TTaoyuan
4Wang LLibo
5Li ZZhaonan
6Jiao DDechao
7Han XXinweihttps://orcid.org/0000-0003-4407-4864

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References54

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128774834Role of Forkhead Box Class O proteins in cancer progression and metastasis.Semin Cancer Biol2018https://conductscience.org/library/papers/28774834PubMed
229170503Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma.Nat Commun2017https://conductscience.org/library/papers/29170503PubMed
325158761Critical limitations of consensus clustering in class discovery.Sci Rep2014https://conductscience.org/library/papers/25158761PubMed
423820108A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer.Clin Cancer Res2013https://conductscience.org/library/papers/23820108PubMed
529514782The MYC oncogene is a global regulator of the immune response.Blood2018https://conductscience.org/library/papers/29514782PubMed
632150830Obatoclax, a Pan-BCL-2 Inhibitor, Downregulates Survivin to Induce Apoptosis in Human Colorectal Carcinoma Cells Via Suppressing WNT/β-catenin Signaling.Int J Mol Sci2020https://conductscience.org/library/papers/32150830PubMed
731537801DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load.Nat Commun2019https://conductscience.org/library/papers/31537801PubMed
832052444KIF18B promotes hepatocellular carcinoma progression through activating Wnt/β-catenin-signaling pathway.J Cell Physiol2020https://conductscience.org/library/papers/32052444PubMed
925601652VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors.J Exp Med2015https://conductscience.org/library/papers/25601652PubMed
1024827502Hypoxia and the extracellular matrix: drivers of tumour metastasis.Nat Rev Cancer2014https://conductscience.org/library/papers/24827502PubMed
1129443960TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.Nature2018https://conductscience.org/library/papers/29443960PubMed
1230098600Role of hypoxia-induced exosomes in tumor biology.Mol Cancer2018https://conductscience.org/library/papers/30098600PubMed
1329301958A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing.Science2018https://conductscience.org/library/papers/29301958PubMed
1431350295The Tumor Microenvironment Innately Modulates Cancer Progression.Cancer Res2019https://conductscience.org/library/papers/31350295PubMed
1523770567Mutational heterogeneity in cancer and the search for new cancer-associated genes.Nature2013https://conductscience.org/library/papers/23770567PubMed
1630061739Molecular therapies and precision medicine for hepatocellular carcinoma.Nat Rev Clin Oncol2018https://conductscience.org/library/papers/30061739PubMed
1729033130Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab.Cell2017https://conductscience.org/library/papers/29033130PubMed
1828637793Endothelial cell metabolism in health and disease: impact of hypoxia.EMBO J2017https://conductscience.org/library/papers/28637793PubMed
1926359337Genomic correlates of response to CTLA-4 blockade in metastatic melanoma.Science2015https://conductscience.org/library/papers/26359337PubMed
2028065785A positive feedback loop between ROS and Mxi1-0 promotes hypoxia-induced VEGF expression in human hepatocellular carcinoma cells.Cell Signal2017https://conductscience.org/library/papers/28065785PubMed

See all 54 referencesDownload CSV of references

Cited by25

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
38632387Single-cell transcriptome analysis profiling lymphatic invasion-related TME in colorectal cancer.Sci Rep2024https://conductscience.org/library/papers/38632387PubMed
37365028[Construction of a prognostic model for hepatocellular carcinoma based on pyroptosis-related genes].Zhonghua Gan Zang Bing Za Zhi2023https://conductscience.org/library/papers/37365028PubMed
37351165
Comprehensive machine learning-generated classifier identifies pro-metastatic characteristics and predicts individual treatment in pancreatic cancer: A multicenter cohort study based on super-enhancer profiling.
Theranostics2023https://conductscience.org/library/papers/37351165PubMed
36282174Comprehensive machine-learning survival framework develops a consensus model in large-scale multicenter cohorts for pancreatic cancer.Elife2022https://conductscience.org/library/papers/36282174PubMed
35967384CD8+ T cell trajectory subtypes decode tumor heterogeneity and provide treatment recommendations for hepatocellular carcinoma.Front Immunol2022https://conductscience.org/library/papers/35967384PubMed
35967375Necroptosis throws novel insights on patient classification and treatment strategies for hepatocellular carcinoma.Front Immunol2022https://conductscience.org/library/papers/35967375PubMed
35662721Title: Multi-Omics and Immune Landscape of Proliferative LncRNA Signatures: Implications for Risk Stratification and Immunotherapy in Hepatocellular Carcinoma.Front Pharmacol2022https://conductscience.org/library/papers/35662721PubMed
35602471Identification and Validation of Immune Molecular Subtypes and Immune Landscape Based on Colon Cancer Cohort.Front Med (Lausanne)2022https://conductscience.org/library/papers/35602471PubMed
35317237Multi-omics landscape and clinical significance of a SMAD4-driven immune signature: Implications for risk stratification and frontline therapies in pancreatic cancer.Comput Struct Biotechnol J2022https://conductscience.org/library/papers/35317237PubMed
35250999Construction of a Lactate-Related Prognostic Signature for Predicting Prognosis, Tumor Microenvironment, and Immune Response in Kidney Renal Clear Cell Carcinoma.Front Immunol2022https://conductscience.org/library/papers/35250999PubMed
35211123The Effect of Hypoxia and Hypoxia-Associated Pathways in the Regulation of Antitumor Response: Friends or Foes?Front Immunol2022https://conductscience.org/library/papers/35211123PubMed
35145517Histone Acetylation Regulator-Mediated Acetylation Patterns Define Tumor Malignant Pathways and Tumor Microenvironment in Hepatocellular Carcinoma.Front Immunol2022https://conductscience.org/library/papers/35145517PubMed
35141223Methylation-Driven Gene PLAU as a Potential Prognostic Marker for Differential Thyroid Carcinoma.Front Cell Dev Biol2022https://conductscience.org/library/papers/35141223PubMed
35083217Immune Landscape Refines the Classification of Colorectal Cancer With Heterogeneous Prognosis, Tumor Microenvironment and Distinct Sensitivity to Frontline Therapies.Front Cell Dev Biol2021https://conductscience.org/library/papers/35083217PubMed
34977116Characterization of Two Ferroptosis Subtypes With Distinct Immune Infiltration and Gender Difference in Gastric Cancer.Front Nutr2021https://conductscience.org/library/papers/34977116PubMed
34970594An Integrated Fibrosis Signature for Predicting Survival and Immunotherapy Efficacy of Patients With Hepatocellular Carcinoma.Front Mol Biosci2021https://conductscience.org/library/papers/34970594PubMed
34970257CD8+ T Cell-Based Molecular Classification With Heterogeneous Immunogenomic Landscapes and Clinical Significance of Clear Cell Renal Cell Carcinoma.Front Immunol2021https://conductscience.org/library/papers/34970257PubMed
34899862Identification of the Immune Cell Infiltration Landscape in Hepatocellular Carcinoma to Predict Prognosis and Guide Immunotherapy.Front Genet2021https://conductscience.org/library/papers/34899862PubMed
34820372Identification of the Pyroptosis-Related Gene Signature for Overall Survival Prediction in Patients With Hepatocellular Carcinoma.Front Cell Dev Biol2021https://conductscience.org/library/papers/34820372PubMed
34760703Computational Recognition and Clinical Verification of TGF-β-Derived miRNA Signature With Potential Implications in Prognosis and Immunotherapy of Intrahepatic Cholangiocarcinoma.Front Oncol2021https://conductscience.org/library/papers/34760703PubMed

See all 25 cited byDownload CSV of cited by

Genes63

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACOT711332PubTator's text mininghttps://conductscience.org/library/genes/11332NCBI Gene
ADM133PubTator's text mininghttps://conductscience.org/library/genes/133NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213NCBI Gene
ALDOA226PubTator's text mininghttps://conductscience.org/library/genes/226NCBI Gene
ANGPTL451129PubTator's text mininghttps://conductscience.org/library/genes/51129NCBI Gene
ARID1A8289PubTator's text mininghttps://conductscience.org/library/genes/8289NCBI Gene
ARID2196528PubTator's text mininghttps://conductscience.org/library/genes/196528NCBI Gene
AXIN18312PubTator's text mininghttps://conductscience.org/library/genes/8312NCBI Gene
BAP18314PubTator's text mininghttps://conductscience.org/library/genes/8314NCBI Gene
BNC1646PubTator's text mininghttps://conductscience.org/library/genes/646NCBI Gene
BRD729117PubTator's text mininghttps://conductscience.org/library/genes/29117NCBI Gene
CA9768PubTator's text mininghttps://conductscience.org/library/genes/768NCBI Gene
CD109135228PubTator's text mininghttps://conductscience.org/library/genes/135228NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD80941PubTator's text mininghttps://conductscience.org/library/genes/941NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CDKN31033PubTator's text mininghttps://conductscience.org/library/genes/1033NCBI Gene
CDO11036PubTator's text mininghttps://conductscience.org/library/genes/1036NCBI Gene

See all 63 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33552157

GET https://conductscience.org/api/papers/v1/33552157/references?page=2